162 related articles for article (PubMed ID: 24358221)
1. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
[TBL] [Abstract][Full Text] [Related]
2. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
[TBL] [Abstract][Full Text] [Related]
3. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
Tang Z; Yu W; Zhang C; Zhao S; Yu Z; Xiao X; Tang R; Xuan Y; Yang W; Hao J; Xu T; Zhang Q; Huang W; Deng W; Guo W
Mol Oncol; 2016 Feb; 10(2):317-29. PubMed ID: 26628108
[TBL] [Abstract][Full Text] [Related]
4. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
5. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
7. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
9. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.
Wu J; Miao J; Ding Y; Zhang Y; Huang X; Zhou X; Tang R
Biochem Cell Biol; 2019 Dec; 97(6):722-730. PubMed ID: 30970220
[TBL] [Abstract][Full Text] [Related]
10. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
[TBL] [Abstract][Full Text] [Related]
11. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
Fu L; Shi K; Wang J; Chen W; Shi D; Tian Y; Guo W; Yu W; Xiao X; Kang T; Wang S; Huang W; Deng W
Mol Cancer; 2014 Apr; 13():89. PubMed ID: 24766673
[TBL] [Abstract][Full Text] [Related]
12. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
Zu Y; Wang D; Ping W; Sun W
Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361
[TBL] [Abstract][Full Text] [Related]
13. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
14. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
15. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.
Lee K; Zheng Q; Lu Q; Xu F; Qin G; Zhai Q; Hong R; Chen M; Deng W; Wang S
Signal Transduct Target Ther; 2021 May; 6(1):184. PubMed ID: 34006850
[No Abstract] [Full Text] [Related]
16. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
Zhang N; Xie Y; Tai Y; Gao Y; Guo W; Yu W; Li J; Feng X; Hao J; Gao Y; Zhao X; Liao Y; Jiang W; Liu G; Deng W; Cui X
Cell Physiol Biochem; 2016; 40(6):1559-1569. PubMed ID: 27997899
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
19. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
20. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
Niu R; Tang Y; Xi Y; Jiang D
J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]